<DOC>
	<DOCNO>NCT00492726</DOCNO>
	<brief_summary>A study compare safety efficacy moxifloxacin ertapenem patient intra-abdominal infection .</brief_summary>
	<brief_title>Therapy Complicated Intra-Abdominal Infections With Moxifloxacin Ertapenem</brief_title>
	<detailed_description />
	<mesh_term>Infection</mesh_term>
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Intraabdominal Infections</mesh_term>
	<mesh_term>Ertapenem</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Norgestimate , ethinyl estradiol drug combination</mesh_term>
	<criteria>Hospitalized men woman &gt; /=18 year age Expected duration treatment intravenous antibiotic anticipate &gt; /= 5 full day exceed 14 day Ability provide document sign write informed consent Confirmed suspect intra abdominal infection define follow : For confirm intra abdominal infection , surgical procedure ( laparotomy laparoscopy ) must perform within 24 hour prior enrollment reveal least one following : Gross peritoneal inflammation purulent exudate ( i.e . peritonitis ) Intra abdominal abscess Macroscopic intestinal perforation localize diffuse peritonitis Subjects enrol basis suspect intra abdominal infection must : Radiological evidence [ abdominal plain film , compute tomography ( CT ) , magnetic resonance imaging ( MRI ) ultrasound ] gastrointestinal perforation intraabdominal abscess follow sign symptom : Symptoms referable abdominal cavity ( e.g . anorexia , nausea , vomit pain ) , last least 24 hour Tenderness ( without rebound ) , involuntary guarding , absent diminish bowel sound , abdominal wall rigidity At least two follow SIRS criterion : Temperature &gt; 38.0°C rectal tympanic membrane , temperature &lt; 36.0°C rectal tympanic Heart rate &gt; 90/min Respiratory rate &gt; 20/min WBC &gt; 12,000 cells/mm3 &lt; 4,000 cells/ mm3 The subject must schedule surgical procedure ( laparotomy laparoscopy ) within 24 hour enrollment study Known hypersensitivity quinolones , and/or carbapenems and/or type beta lactam antibiotic drug ( e.g . penicillin cephalosporin ) , excipients Women pregnant lactating pregnancy exclude History tendon disease/disorder relate quinolone treatment Known congenital document acquire QT prolongation ; uncorrected hypokalemia ; clinically relevant bradycardia ; clinically relevant heart failure reduce leave ventricular ejection fraction ; previous history symptomatic arrhythmia Concomitant use follow drug , report increase QT interval : antiarrhythmic class IA ( e.g . quinidine , hydroquinidine , disopyramide ) antiarrhythmic class III ( e.g. , amiodarone , sotalol , dofetilide , ibutilide ) , neuroleptic ( e.g . phenothiazine , pimozide , sertindole , haloperidol , sultopride ) , tricyclic antidepressive agent , certain antimicrobial ( sparfloxacin , erythromycin IV , pentamidine , antimalarial , particularly halofantrine ) , certain antihistaminics ( terfenadine , astemizole , mizolastine ) , others ( cisapride , vincamine IV , bepridil , diphemanil ) Known severe end stage liver disease Creatinine clearance &lt; /= 30 mL/min/1.73 m2 Systemic antibacterial therapy administer 24 hour within 7 day enrollment Need systemic antibacterial therapy agent describe study protocol Indwelling peritoneal catheter Pre exist ascites presume spontaneous bacterial peritonitis Perforation stomach duodenum , duration perforation le 24 hour operate within 24 hour perforation Perforation small bowel ( exclude duodenum ) large bowel , duration perforation le 12 hour operate within 12 hour perforation All pancreatic process include pancreatic sepsis , peripancreatic sepsis , intra abdominal infection secondary pancreatitis Liver splenic abscess Transmural bowel ischemia necrosis without perforation establish peritonitis abscess Acute gangrenous cholecystitis without perforation Acute cholangitis Early acute , suppurative , gangrenous nonperforated appendicitis Subjects require antibiotic irrigation abdominal cavity surgical wound Treatment `` open abdomen '' marsupialization , multiple plan laparotomy Infections originate female genital tract Perinephric infection Evidence sepsis shock require administration vasopressor 4 consecutive hour Known rapidly fatal underlying disease ( death expect within 6 month ) Neutropenia ( neutrophil count &lt; 1,000/mL ) cause immunosuppressive therapy malignancy Receiving chronic treatment know immunosuppressant therapy ( include chronic treatment &gt; 15 mg/day systemic prednisone equivalent ) Subjects know AIDS ( CD4 count &lt; 200/mL ) HIV seropositives receive HAART ( HIV positive subject may include . HIV test require study protocol ) Subjects malignant pre malignant hematological condition , include Hodgkin 's disease nonHodgkin lymphoma ( subject solid tumor include study ) Subjects Body Mass Index &gt; /= 45 kg/m2 Previous enrollment study Participation clinical investigational drug study within previous 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>Complicated Intra-Abdominal Infections</keyword>
</DOC>